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Sequences encoding the major and minor capsid proteins (VP1 and VP2) from two marine
vesivirus isolates (Steller sea lion viruses V810 and V1415) were engineered for expression
of virus-like particles (VLPs) in the baculovirus system. The resulting VLPs were
morphologically similar to native vesivirus virions. Puriﬁed VLPs were probed in
immunoblots with pooled antisera speciﬁc for nine San Miguel sea lion virus (SMSV) types,
and a predominant protein of approximately 60 kDa was detected. An enzyme linked
immunosorbent assay (ELISA) for the detection of antibodies was developed in which the
VLPs served as antigen. The VLPs were adsorbed to the wells of a microplate, and the
speciﬁcity of the ELISA was established with hyperimmune sera raised against 24
serotypes of the genus Vesivirus. The ELISA was used to screen for the presence of vesivirus
speciﬁc antibodies in the sera of free-ranging Steller sea lions. The ELISA results
demonstrated that Steller sea lions that inhabit the Paciﬁc Ocean waters of southeast
Alaska are widely exposed to antigenically related marine vesiviruses, while no previous
exposure could be demonstrated using VLP antigens in 17 Steller sea lions from the
Aleutian Islands. The broad reactivity of these VLPs and their non-infectious nature will
facilitate global sero-epidemiological studies aimed at determining the incidence and
prevalence of marine vesiviruses in mammals that inhabit the Paciﬁc and Atlantic oceans
as well as susceptible terrestrial animals.
ß 2009 Elsevier B.V. All rights reserved.
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1. Introduction
Members of the genus Vesivirus in the family Caliciviridae infect both marine and terrestrial organisms (Smith
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romerohcarlos@gmail.com (C.H. Romero).

and Boyt, 1990). Among vesiviruses known collectively as
the ‘‘marine vesiviruses’’ are 13 serotypes isolated from
swine between 1932 and 1956 called vesicular exanthema
of swine viruses (VESVs), which are considered foreign
animal disease (FAD) agents in the USA because they
sometimes cause a vesicular disease in swine clinically
indistinguishable from foot-and-mouth disease. It has
been proposed that the VESV strains were accidentally
introduced into pig herds through the ingestion of feed
contaminated with marine mammal and ﬁsh products
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harboring serologically related vesiviruses (Smith et al.,
1973). Working with these viruses requires their handling
in at least a BSL-2 plus or enhanced biosafety laboratory
and special USDA-APHIS permits. Due to these restrictions,
research on marine vesiviruses has been hampered and
diagnostic reagents are not readily available to study the
distribution and impact of marine vesiviruses in marine or
terrestrial animals. The identiﬁcation of marine vesiviruses
initially relied on virus isolation in cell culture and virus
neutralization (VN) using panels of speciﬁc antisera raised
against different isolates (Smith and Akers, 1976; Smith
and Boyt, 1990). Although more than 45 serotypes have
been established with this approach, the extent of
serotypic diversity among these viruses in not known. In
recent years, molecular approaches have been developed
to detect and genotype new isolates (McClenahan et al.,
2008; Reid et al., 1999, 2007).
Although the genotype of new isolates can be determined by nucleotide sequencing and phylogenetic analyses (Berke et al., 1997; Ganova-Raeva et al., 2004;
McClenahan et al., 2008; Neill, 1992), additional studies
are needed to understand the relationship between
genotype and serotype. Moreover, the availability of
non-restricted (non-infectious) vesivirus serologic assays
would facilitate studies of the natural history of marine
vesiviruses in their vast ecosystem. In this context, viruslike particles (VLPs) are empty viral capsids that resemble
the capsid of the native virus, but that do not contain the
infectious viral RNA that characterizes all members of the
family Caliciviridae (Ball et al., 1996; Bertolotti-Ciarlet
et al., 2003; Di Martino et al., 2007; Jiang et al., 1992;
Laurent et al., 1994; Noad and Roy, 2003). The generation
of the ﬁrst calicivirus VLPs was reported for the Norwalk
virus, a member of the genus Norovirus, following coexpression of ORF2 and ORF3 in a single baculovirus (Jiang
et al., 1992). In members of the genus Vesivirus, the
complete capsid gene (ORF2) is translated as a precursor
protein approximately 73 kDa that is cleaved by the viral
protease encoded in ORF1 to generate a mature capsid
protein (VP1) of approximately 60 kDa (Carter et al., 1992;
Neill et al., 1991). Virus-like particles have also been
produced from the vesivirus feline calicivirus (FCV) by
expressing either the capsid precursor or mature capsid
protein in a baculovirus expression system (DeSilver et al.,
1997; Di Martino et al., 2007). However, although the
development of marine vesivirus VLPs has not been
reported, recombinant antigens of broader reactivity to
detect marine vesivirus antibodies have been recently
described; i.e., a recombinant antigen (D3A) of 293 amino
acids corresponding to a capsid fragment of San Miguel sea
lion virus 5 (SMSV-5) expressed in a bacterial system was
reactive with antisera to more than 30 different serotypes
of marine vesiviruses (Kurth et al., 2006a). The antigen was
also used to detect vesivirus antibodies in 15% (n = 693) of
serum samples from sick and healthy cattle (Kurth et al.,
2006a), and in the serum of mares that had aborted; in
which an increase in the frequency of antibodies from 47.1
to 88.2% was demonstrated (Kurth et al., 2006b).
We recently reported the isolation and characterization
of two unique marine vesivirus genotypes from Steller sea
lions (SSL-Eumetopias jubatus), SSL V810 and SSL V1415
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(McClenahan et al., 2008). We report here the production
of VLPs from these two genotypes by expression of their
mature VP1 or VP1 and VP2 capsid proteins in a
baculovirus system. The VLPs were utilized as antigens
to develop an enzyme linked immunosorbent assay (ELISA)
for the detection of serum antibodies to marine vesiviruses
in animals from two free-ranging populations of SSL in
Alaska.
2. Materials and methods
2.1. Viral RNA
Marine vesiviruses SSL V810 and SSL V1415 were
isolated from Alaskan Steller sea lions in Vero and Madin
Darby canine kidney (MDCK) cell cultures, respectively
(McClenahan et al., 2008). After the fourth passage in Vero
cell cultures, total RNA was extracted from the cell
monolayers at the height of cytopathogenic activity using
TRIzol-LS (Invitrogen, Carlsbad, CA) following the manufacturer’s protocol.
2.2. Construction of recombinant baculoviruses
Oligonucleotide primers were designed to amplify the
mature capsid gene (VP1) from the SSL vesiviruses V810
and V1415. Primers BacVFW-ORF2 (CACCATGTCGGATGGTCCAG) and BacVRV-ORF2 (TCCAAAATTTGCATAATTCAT) were used to amplify a fragment of
approximately 1680 nucleotides (nt). During natural
vesivirus infection, the mature capsid protein is produced
post-translationally after cleavage of the full-length
precursor of the capsid protein by the virus-encoded
proteinase, so an ATG sequence was engineered into the
forward primer. Separate baculovirus constructs were also
created to express the VP1 and the protein product of ORF 3
(VP2) from a single template. BacVFW-ORF2 was used as
the forward primer and BacVRV-ORF3 (GCAACCTACCAATTAACTAATTC) as the reverse primer to generate a PCR
fragment of approximately 2170 nt.
All ampliﬁed PCR products were cloned into the
Gateway vector, pENTR (Invitrogen) by Topo cloning and
plasmids containing the desired inserts were veriﬁed by
sequence analysis. Plasmid DNA was then added to a
reaction mix containing baculovirus DNA (Baculodirect kit,
Invitrogen), and the recombination reaction was performed according to the manufacturer’s instructions. A
transfection mixture was prepared that contained 250 ng
recombinant baculovirus DNA, 6 ml of Cellfectin (Invitrogen), and 2 ml unsupplemented Grace’s Medium (Invitrogen). Following incubation at room temperature for
45 min, the mixture was added to Sf-9 cells seeded at
8  105 cells per well in a 6-well plate. The transfection
mixture and cells were incubated for 5 h at 28 8C, after
which the transfection mixture was removed and replaced
with 2 ml serum-free HyQ Medium (HyClone, Logan, UT)
containing 100 mg/ml ganciclovir, as a negative selection
agent, and supplemented with penicillin, streptomycin
and Amphotericin B. The cultures were incubated at 28 8C
for 5 days and the cells and supernatants were harvested as
the ﬁrst passage (P1) viral stock. The P1 viral stock (5 ml)
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was added to a fresh Sf-9 monolayer in the well of a 6-well
plate and maintained in the presence of 100 mg/ml
ganciclovir for 120 h. The resulting P2 viral stock was
veriﬁed as free of wild-type baculovirus with a b-gal kit
(Invitrogen), and then used to infect a 100 ml suspension
culture of Sf-9 cells at a multiplicity of infection (MOI) of
0.5 in the absence of ganciclovir. The resulting P3 viral
stock was titrated by plaque assay on Sf-9 cell cultures in
6-well plates, and used to infect Sf-9 suspension cultures at
a MOI of 3 for protein expression and puriﬁcation.
2.3. Protein puriﬁcation
Recombinant viruses were propagated in suspension
cultures of Sf-9 cells grown in 150-ml of HyQ medium. Five
days post-infection the cultures were harvested, frozen
and thawed twice, and clariﬁed by low-speed centrifugation. The supernatants were layered onto a 25% sucrose
cushion and subjected to centrifugation in a SW28 rotor at
24,000 rpm for 4 h at 4 8C. The resulting pellets were
dissolved in phosphate buffered saline (PBS) pH 7.5 and
further puriﬁed through a cesium chloride (CsCl) gradient.
The samples were mixed with 1.6 g/cm3 of CsCl to produce
a ﬁnal density of 1.38 g/cm3 as veriﬁed by refractometry.
The samples were centrifuged in a SW55Ti rotor at
48,000 rpm for 18 h at 15 8C and visible bands were
collected with a needle and syringe. The collected fractions
were dialyzed against PBS to remove the CsCl using a SlideA-Lyzer cassette (Pierce, Rockford, IL), and the protein
concentration was determined with a commercial Bradford assay kit (Pierce).
2.4. SDS-PAGE and immunoblotting
The protein samples were mixed with sample loading
buffer containing 2% sodium-dodecyl sulfate (SDS), 0.5 M
Tris–HCl, pH 6.8, 25% glycerol, 0.5% bromophenol blue, and
2% beta-mercaptoethanol and heated at 95 8C for 5 min.
The denatured proteins were resolved by SDS polyacrylamide gel electrophoresis (SDS-PAGE) in 4–20% gradient
gels (Lonza, Basel, Switzerland) run at 125 V for 1.5 h with
a protein standard (Invitrogen). Proteins were transferred
onto a polyvinylidene diﬂuoride (PVDF) membrane (Invitrogen) for 7 min using the iBlot Gel Transfer Device
(Invitrogen). In the immunoblot analysis, the PVDF
membrane was blocked for 1 h at room temperature in
Blotto buffer (5% dried non-fat milk in PBS). The membrane
was then incubated with a mixture of polyclonal antisera
speciﬁc for SMSV serotypes; 1, 2, 4, 5, 6, 9, 10, 11, and 13,
diluted to 1:2000 in Blotto, incubated for 1 h with shaking
and then overnight at 4 8C. The membrane was washed
four times, 5 min each time, with Western Breeze wash
buffer (Invitrogen) and incubated at room temperature for
1 h with goat anti-rabbit IgG-alkaline phosphatase conjugate (Pierce) (diluted 1:1000 in blocking buffer) in order
to detect binding of the primary antibodies. The membrane
was washed four times for 10 min before incubation with
the substrate BCIP/NBT (Zymed lab, South San Francisco,
CA) for 5 min at room temperature. The reaction was
stopped with water and the membranes were dried prior
to photography.

2.5. Electron microscopy
Electron microscopy was used to visualize the VLPs
expressed from the recombinant baculoviruses. The
puriﬁed VLPs were adsorbed onto Formvar-coated grids,
stained with phosphotungstic acid (PTA), blotted dry, and
examined with a FEI Tecnai 12 electron microscope.
2.6. Enzyme linked immunosorbent assay
The VLPs produced from recombinant baculoviruses
expressing the mature capsid protein VP1 of vesivirus
isolates SSL V810 and SSL V1415 were each employed as an
antigen in the development of an ELISA modeled on
previously described assays (Barajas-Rojas et al., 1993;
Crowther, 2001; Ferris and Oxtoby, 1994; Kurth et al.,
2006a,b). The VLPs were diluted in carbonate–bicarbonate
buffer pH 9.5 (Sigma) to a ﬁnal concentration of 1 mg/ml and
100 ml of the dilution was added per well of a 96-well
MaxiSorp polystyrene plate (Nunc, Roskilde, Denmark).
Following adsorption of the antigen at 4 8C overnight, the
wells were washed once with 200 ml wash buffer (Trisbuffered saline with 0.1% Tween 20 [TBST]) and blocked with
200 ml of blocking buffer (5% non-fat dried milk in TBST) for
1 h at 37 8C. Rabbit polyclonal antisera against various SMSV
and VESV serotypes and serum or plasma collected from
free-ranging marine mammals (primary reagents) were
titrated by performing serial two-fold dilutions in the plate
beginning at a 1:50 dilution in TBST containing 1% non-fat
dried milk (TBST-blotto). Each serum sample was also tested
in at least three wells not coated with VLPs (no antigen wells)
to determine its non-speciﬁc absorbance background. The
plates were incubated for 1 h at 37 8C and subsequently
washed six times with TBST buffer. The optimal dilution
(1:3000) of the secondary reagent, protein A-peroxidase
conjugate, was determined by checkerboard titration of a
0.5 mg/ml stock (Pierce) diluted in TBST-blotto, and 100 ml of
the optimal dilution was added to each well. The plate was
incubated at 37 8C for 1 h, followed by four washes with
200 ml of TBST per well. The ABTS (2,20 -azino-bis 3ethylbenzthiazoline-6-sulfonic acid; Kirkegaard & Perry
Laboratories, Gaithersburg, MD) substrate (100 ml) was
added to each well and the plates were incubated for 30 min
at room temperature. The absorbance of each reaction was
read at 405 nm on a Synergy plate reader (Bio-Tek, Winooski,
VT). A serum sample was considered to contain antibodies to
marine vesiviruses if two criteria were met simultaneously.
First, the corrected absorbance value (VLP antigen absorbance minus no antigen absorbance) was 0.200 or greater,
and second, if the index was equal or greater than 2.0 (VLP
antigen absorbance divided by no antigen absorbance). Each
serum sample was tested in triplicate in the blank wells. The
titer for each serum sample was expressed as the reciprocal
of the highest dilution that was positive by the two criteria
above.
2.7. Serum and plasma samples assayed in the ELISA and
virus neutralization test
Hyperimmune reference sera prepared in rabbits
speciﬁc for the various SMSV and VESV strains (Seal
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et al., 1995) were obtained from the National Animal Disease
Center, USDA, Ames, Iowa, and were assayed for their
reactivity in the ELISA. These included sera speciﬁc for SMSV
1, 2, 4, 5, 6, 7, 9, 10, 11, 13, VESV-A48, B51, C52, D53, E54, F55,
G55, H54, I55, J56, K54, and 1934B. Hyperimmune sera
raised against FCV and mink calicivirus (MCV), both
members of the genus Vesivirus were also examined. Serum
samples were obtained from free-ranging SSL, including 41
samples from Southeastern Alaska collected in 2004 and 17
SSL samples from the Aleutian Islands, Alaska, collected in
2005. Some sera were stored at 4 8C for several days before
long-term storage at 20 8C or 70 8C. The virus neutralization (VN) test was performed as previously described
(McClenahan et al., 2008).
3. Results
3.1. Baculovirus expression of vesivirus capsid proteins
Recombinant baculoviruses expressing the VP1 protein
from SSL vesiviruses V810 and V1415 were constructed by
inserting an 1680-bp fragment of the vesiviruses VP1
gene into the baculovirus genome. A third recombinant
baculovirus was constructed by insertion of an 2170-bp
fragment corresponding to the V810 VP1 + VP2 genes into
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the baculovirus genome. These recombinant viruses were
propagated twice in Sf-9 cell cultures, in the presence of
ganciclovir to screen out non-recombinant wild-type
baculovirus. Recombinant baculoviruses expressing V810
VP1, V1415 VP1, or V810 VP1 + VP2 were titrated in a
plaque-forming assay and exhibited titers of 2.3  107,
2.5  107, and 3.0  107 PFU/ml, respectively. Each of the
three recombinant baculoviruses was used to infect 150ml suspensions of Sf-9 cell cultures at a MOI of 3. A 500 ml
sample was collected daily and the cell viability was
determined. Cell viability was over 95% prior to infection
and decreased over time, reaching 30% viability at day 5 in
all three infected cell cultures. Daily samples collected on
days 1 through 5 were analyzed by SDS-PAGE for protein
expression. The presence of an approximately 60 kDa
protein was apparent in extracts from the infected cell
pellets and in supernatants harvested from all three
recombinant baculoviruses, but not in the mock infected
cell controls (Fig. 1A–C). The baculovirus-infected material
was then subjected to isopycnic centrifugation as
described in Section 2. A visible band corresponding to a
density of 1.29 g/cm3 was evident in the upper half of the
CsCl gradient, consistent with the isolation of recombinant
VLPs. The analysis of the material in this band by SDS-PAGE
showed the presence of an expected 60 kDa protein

Fig. 1. SDS-PAGE analysis of SSL vesivirus proteins produced in the baculovirus expression system. Proteins were separated by SDS-PAGE and stained with
Gel Code Blue (Invitrogen). (Panels A–C) Samples were harvested daily for 5 days from recombinant baculovirus-infected Sf-9 cell cultures. Lane 1:
molecular weight marker, lanes 2 through 6: daily collections from cell pellets, lanes 7 through 11: daily collections from cell culture supernatant, lane 12:
uninfected Sf-9 cell control. (Panel A) V810 VP1, (panel B) V1415 VP1, (panel C) V810 VP1 + VP2, (panel D) proteins puriﬁed from cesium chloride gradients
of the supernatant from day 5 from the 3 recombinant viruses. Lane 1: molecular weight marker, lane 2: V810 VP1, lane 3: V1415 VP1, lane 4: V810
VP1 + VP2.
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Fig. 2. Immunoblot analysis of SSL vesivirus VP1 proteins expressed in the baculovirus expression system. The panels are the same as described above for
Fig. 1. The viral proteins were detected using a 1:2000 dilution of a mixture of type speciﬁc antibodies to San Miguel sea lion virus (SMSV) serotypes 4, 6, 9,
10, 11, and 13. A 60 kDa protein consistent with the positive control vesiviruses V810 and V1415 (panel D, lanes 5 and 6) was detected from the daily
samples and from VLPs puriﬁed in cesium chloride gradients.

(Fig. 1D). A protein of approximately 58 kDa co-puriﬁed
with the capsid protein in the CsCl gradient, but its identity
was not determined (Fig. 1D), consistent with the
appearance of ‘‘doublet’’ bands observed sometimes in
capsid expression studies of the caliciviruses (Belliot et al.,
2001; Kitamoto et al., 2002; Taube et al., 2005). Additional
studies will be needed to determine whether the smaller
58 kDa vesivirus protein was generated by mechanisms
such as proteolytic cleavage (degradation), alternative
processing in the baculovirus system, or initiation from an
internal methionine on the messenger RNA.
A time course analysis of VP1 expression in insect cells
was examined by immunoblotting. Baculovirus-infected
Sf-9 cell lysates in the blot were probed with a mixture of
hyperimmune sera raised against SMSV strains as
described in Section 2.4. A protein of approximately
60 kDa was detected that increased in intensity over time

(Fig. 2A–C). This protein corresponded in size to the mature
VP1 protein detected in lysates of Vero cell cultures
infected with SSL vesiviruses V810 and V1415 (Fig. 2D).
3.2. Electron microscopy
Negative staining and electron microscopy of puriﬁed
protein samples from both VP1 recombinants and the
VP1 + VP2 recombinant baculoviruses revealed the presence of VLPs consistent in size (32–35 nm) and shape to
native calicivirus virions (Fig. 3).
3.3. Detection of vesivirus antibodies by ELISA
3.3.1. ELISA antibody titers of SMSV and VESV antisera
The reactivities of a panel of rabbit hyperimmune sera
directed against several SMSV and VESV strains of varying

Fig. 3. Electron micrograph of virus-like particles (VLPs) expressed in the baculovirus expression system. Proteins were visualized by negative staining with
phosphotungstic acid. Shown are representative images of VLPs derived from vesivirus strain: V1415 (VP1 only—panel A), V810 (VP1 only—panel B), and
V810 (VP1 + VP2—panel C).
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Table 1
Antibody titers obtained by virus neutralization (VN) and enzyme linked immunosorbent assay (ELISA). Speciﬁc antisera to various marine vesiviruses
(SMSV) and vesicular exanthema of swine virus (VESV), as well as antisera to feline calicivirus and mink calicivirus VLPs were assayed by VN with infectious
virus and by ELISA with VLP antigens. ND: not done.
Antiserum

V810 VLP ELISA titer

V810 VN titer

V1415 VLP ELISA titer

V1415 VN titer

SMSV-1
SMSV-2
SMSV-4
SMSV-5
SMSV-6
SMSV-7
SMSV-9
SMSV-10
SMSV-11
SMSV-13
VESV-A48
VESV-B51
VESV-C52
VESV-D53
VESV-E54
VESV-F55
VESV-G55
VESV-H54
VESV-I55
VESV-J56
VESV-K54
VESV-1934B
Feline calicivirus
Mink calicivirus

6,400
12,800
3,200
25,600
200
25,600
6,400
12,800
6,400
25,600
800
3,200
6,400
25,600
6,400
1,600
12,800
12,800
12,800
3,200
3,200
25,600
25,600
800

<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
4
<4
<4
<4
<4
<4
<4
<4
<4
ND
ND

3,200
6,400
3,200
25,600
200
25,600
6,400
6,400
6,400
25,600
1,600
3,200
25,600
25,600
12,800
3,200
12,800
12,800
12,800
3,200
3,200
25,600
25,600
1,600

<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
4
<4
<4
<4
<4
<4
<4
<4
<4
ND
ND

serotype were examined in the ELISA using SSL vesiviruses
V810 and V1415 VLPs (Table 1). SMSV antiserum titers
ranged from 200 to 25,600, while VESV antiserum titers
ranged between 800 and 25,600 when tested against
V810 VLPs. SMSV antiserum titers ranged from 200 to
25,600 while VESV antiserum titers ranged between
1,600 and 25,600 when assayed against V1415 VLPs.
Speciﬁc antisera raised against other Vesivirus genus
members including FCV and MCV virions also reacted
with SSL vesivirus VLPs with titers as high as 25,600 for
FCV antiserum, and 800 and 1600 for MCV antiserum
(Table 1).
3.3.2. ELISA titers of marine mammal sera
A total of 58 serum samples obtained in 2004 from freeranging marine mammals from Southeast Alaska, and in
2005 from the Aleutian Islands, Alaska, were tested in the
V810 and V1415 ELISA for speciﬁc antibodies. When 41 sera
collected from young free-ranging SSL from Southeast
Alaska were assayed by ELISA, 36 (87.8%) were positive
for antibodies reacting with the V810 VLPs and 38 (92.7%)
were positive for the V1415 VLPs (Table 2). Antibody titers
against isolate V810 VLPs ranged from 50 to 800 with a
median of 200 while titers against isolate V1415 VLPs ranged
from 100 to 12,800 with a median of 400 (not shown). Virus
neutralizing antibody titers were demonstrated in 27
(65.9%) of 41 sera tested against isolate V810 and in 38
(92.7%) of 41 sera tested against isolate V1415 (Table 2). The
median VN antibody titer was 16 against isolate V810 and
512 against isolate V1415 (not shown). Except for four
borderline results, all 17 sera obtained in 2005 from SSL from
the Aleutian Islands were negative for ELISA vesivirus
antibodies. The same 17 SSL sera were also negative for VN
antibodies against isolates V810 and V1415 (Table 2).

4. Discussion
The major capsid protein (VP1) of two recently
characterized SSL vesiviruses; V810 and V1415, was
expressed in the baculovirus system. The expressed VP1
(with or without the presence of VP2) self-assembled into
VLPs. This is an advance in the study of marine vesiviruses
because recombinant VLPs are nearly indistinguishable
from native virions, and therefore have the potential for
use as non-infectious antigens in diagnostics assays (Ball
et al., 1996). In the host, after natural infection with
caliciviruses, the most abundantly produced antibodies are
directed against the capsid protein, and a signiﬁcant
proportion of these antibodies have type-speciﬁc neutralizing activity (Guiver et al., 1992; Matsuura et al., 2001;
Neill et al., 1991; Tohya et al., 1991). The availability of
recombinant VLPs should also facilitate the study of
antigenic relationships among the marine vesiviruses by
providing an unlimited supply of immunogens for the
production of antisera against structural (capsid) proteins.
Such sera would enable the rapid characterization of new
vesivirus strains, and provide reference standards in the
development and validation of diagnostic assays.
Although vesiviruses encode a precursor of the capsid
protein in ORF2, we engineered the baculoviruses to
express only the predicted processed form of the VP1 by
engineering an ATG codon at the 50 -end of the VP1 gene
cloned into the recombinant baculovirus. In addition, a
recombinant baculovirus also yielded VLPs when the
complete VP2 gene sequences encoded in ORF3 were
included with those of the VP1. Like other caliciviruses, the
VP1 gene of marine vesiviruses alone seems sufﬁcient for
assembly of the VLPs and the co-expression of VP2 is not
necessary for capsid formation (Bertolotti-Ciarlet et al.,
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Table 2
Antibody titers in the serum of Steller sea lions against marine vesiviruses as determined by virus neutralization (VN) using isolates V810 and V1415 and
ELISA using VLPs from the same isolates as antigen. SSL: Steller sea lion; SE: Southeast Alaska; AL: Aleutian Islands, Alaska.
Serum sample

V810 VLP ELISA titer

V810 VN titer

V1415 VLP ELISA titer

V1415 VN titer

SSL2004-499SE
SSL2004-500SE
SSL2004-501SE
SSL2004-502SE
SSL2004-503SE
SSL2004-504SE
SSL2004-505SE
SSL2004-506SE
SSL2004-507SE
SSL2004-508SE
SSL2004-509SE
SSL2004-510SE
SSL2004-511SE
SSL2004-512SE
SSL2004-513SE
SSL2004-514SE
SSL2004-515SE
SSL2004-516SE
SSL2004-517SE
SSL2004-518SE
SSL2004-519SE
SSL2004-520SE
SSL2004-521SE
SSL2004-522SE
SSL2004-523SE
SSL2004-524SE
SSL2004-525SE
SSL2004-526SE
SSL2004-527SE
SSL2004-528SE
SSL2004-529SE
SSL2004-530SE
SSL2004-531SE
SSL2004-532SE
SSL2004-533SE
SSL2004-534SE
SSL2004-535SE
SSL2004-536SE
SSL2004-537SE
SSL2004-538SE
SSL2004-539SE
SSL2005-594AL
SSL2005-595AL
SSL2005-596AL
SSL2005-597AL
SSL2005-598AL
SSL2005-599AL
SSL2005-600AL
SSL2005-601AL
SSL2005-602AL
SSL2005-603AL
SSL2005-604AL
SSL2005-605AL
SSL2005-606AL
SSL2005-607AL
SSL2005-608AL
SSL2005-609AL
SSL2005-610AL

200
100
100
<50
200
400
400
200
400
50
800
200
200
<50
200
400
50
100
400
100
100
200
100
400
200
800
800
100
800
400
50
100
100
50
200
800
<50
100
<50
100
<50
<50
<50
<50
<50
<50
50
<50
<50
50
<50
50
<50
<50
<50
<50
<50
<50

<4
<4
4
<4
4
<4
<4
1024
4
32
16
8
16
8
4
32
<4
<4
<4
<4
128
64
<4
16
4
64
16
32
16
4
4
4
16
64
8
1024
8
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4

800
800
800
<50
800
400
800
200
400
800
200
400
800
200
3,200
6,400
400
100
12,800
800
200
1,600
100
800
200
3,200
800
200
400
800
200
200
800
200
3,200
400
<50
400
200
200
<50
<50
<50
50
<50
<50
<50
<50
<50
50
<50
50
<50
<50
<50
<50
<50
<50

128
8192
512
16
512
8
64
512
1024
512
2048
256
4096
8192
16
512
512
32
1024
4096
2048
2048
32
8
8
2048
<4
8
<4
1024
<4
128
2048
64
8192
8
128
1024
1024
512
8
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4

2003; Di Martino et al., 2007). The ORF3 protein product
has an unknown function, but due to the basic characteristic of the VP2 protein, it has been proposed to interact
with the viral RNA and possibly, to encapsidate the RNA of
progeny viruses (Neill et al., 1991; Prasad et al., 1999). The
VP2 protein has been shown to be a structural protein
(Glass et al., 2000; Sosnovtsev and Green, 2000), and is

necessary for infection of FCV (Sosnovtsev et al., 2005).
Previous experiments with noroviruses indicated that VLPs
expressed from ORF2 and ORF3 sequences had higher
yields than when expressed from ORF2 alone, and the VLPs
showed increased stability (Bertolotti-Ciarlet et al., 2003).
In the present study, it appeared that the V810 vesivirus
VLPs produced with both VP1 + VP2 genes exempliﬁed the

S.D. McClenahan et al. / Veterinary Microbiology 142 (2010) 184–192

traditional ‘‘cup-like’’ morphology of members of the
Caliciviridae, but further experimentation will be needed to
determine whether there are advantages to co-expressing
VP1 and VP2 of these marine vesiviruses.
A new ELISA was developed using non-infectious VLPs
expressed from recombinant baculoviruses as antigen
coated on microtiter plate wells. Rabbit origin typing sera
against 22 marine vesiviruses (10 serotypes designated
SMSVs and 12 serotypes designated VESVs) were crossreactive with VLPs produced from SSL vesivirus strains
V810 and V1415. However, none of these antisera
neutralized SSL isolates V810 and V1415, indicating that
these two viruses did not belong to any of the known VESV
or SMSV serotypes tested. These ﬁndings also indicated
that the V810 and V1415 VLPs can serve as broadly reactive
antigens, which recognize antibodies against many known
marine vesivirus types and strains. Recently described
ELISAs for the detection of antibodies against marine
vesiviruses have in addition to the VLPs reported here,
used both a bacterially expressed peptide, D3A and pooled
whole viruses (SMSVs 5, 13, and 17) as coating antigens
(Kurth et al., 2006a,b; Smith et al., 2006). These ELISA
coating antigens were reported to be cross-reactive with
more than 14 different marine vesivirus serotypes, which
is similar to the cross-reactivity of the VLPs described here.
The VLP-based ELISA was used in a serologic survey of
Steller sea lions living near southeast Alaska in 2004 and
the Aleutian Islands in 2005. Each of the 58 SSL sera was
assayed by VN against vesiviruses V810 and V1415, and by
ELISA against VLPs produced by recombinant baculoviruses expressing VP1 from isolates V810 and V1415.
Over 90% of the tested animals in Southeast Alaska were
positive for one or both vesiviruses in the ELISA. In
addition, ELISA and VN antibodies against V1415 VLPs and
the 2005 viral isolate V1415, respectively, were present in
higher titer and frequency than similar antibodies against
the V810 VLPs and the 2002 viral isolate V810. These
results may reﬂect a more recent exposure to vesivirus SSL
V1415-like strains circulating in 2004 versus vesivirus SSL
V810-like strains circulating in 2002 in the same population of SSL in Southeast Alaska. An interesting ﬁnding was
the identiﬁcation of 17 antibody-negative serum samples
collected in 2005 from SSL in the Aleutian Islands (Table 2).
Further screening of SSLs from this area in the near future
will be needed to determine whether animals in this
rookery have remained free of exposure to marine
vesiviruses.
In summary, we report the development, expression
and production of VLPs of marine vesiviruses from
recombinant baculoviruses, in which either the mature
capsid gene VP1 or both VP1 and VP2 sequences had been
introduced. These VLPs were consistent in appearance
with native virions both in size and structure, and the VLPs
containing VP1 were successfully used to develop an ELISA
for the detection of vesivirus antibodies. The ELISA was
shown to detect antibodies in reference hyperimmune
rabbit sera raised in the laboratory against 24 different
vesiviruses, including 12 VESV serotypes that were
isolated decades ago (1932–1956) and in the sera of
free-ranging Steller sea lions undergoing natural vesivirus
infection 4–7 years ago (2002–2005). The ELISA will make
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possible for the ﬁrst time, the large-scale screening of
marine mammals for infection with vesiviruses in seroepidemiological studies both in the North Paciﬁc Ocean
waters, known to be a natural habitat of these viruses
(Burek et al., 2005; Skilling et al., 1987; Smith et al., 1973),
as well as in the Atlantic Ocean and Gulf of Mexico waters,
from where marine vesiviruses have not yet been isolated.
This ELISA will contribute also to the screening of
terrestrial mammals for potential exposure to pathogenic
marine vesiviruses or related vesivirus strains. Because
certain marine vesiviruses (VESVs) are restricted agents by
virtue of inducing clinical signs in swine indistinguishable
from those of foot-and-mouth disease, these safe, nonreplicating VLP antigens can now be used safely in
conventional diagnostic virology laboratories and in basic
calicivirus research.
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